OncoSec Medical
About:
OncoSec is a biotechnology company focusing on designing and developing gene therapies, therapeutics, and medical approaches.
Website: http://oncosec.com
Twitter/X: Oncosec
Top Investors: National Institutes of Health, Alpha Holdings
Description:
OncoSec Medical is an advanced-stage biomedical company that focuses on the development of novel therapeutic oncology products. The company's core technology is an untapped delivery system, that applies short electric impulses to a tumor, causing transient pores to open in the cellular membrane, allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS electroporation. Using OMS electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded among predominantly healthy tissue.
$143M
$10M to $50M
San Diego, California, United States
2008-01-01
investors(AT)oncosec.com
Punit Dhillon
51-100
2023-05-16
Public
© 2025 bioDAO.ai